🎁 Black Friday: up to 50% off of annual plans
G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
22.50
-2.50 (-10.00%)
Nov 20, 2026, 1:30 PM CST

G&E Herbal Biotechnology Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
170.13309.13249.03181.4464.6124.57
Revenue Growth
-45.43%24.13%37.25%180.84%162.94%-12.96%
Cost of Revenue
40.0645.9143.6936.8625.2514.95
Gross Profit
130.06263.22205.34144.5939.359.63
Selling, General & Admin
56.1476.0350.3639.319.4816.65
Research & Development
26.7634.8935.3424.614.3912.54
Operating Expenses
82.9110.9285.763.933.8729.19
Operating Income
47.17152.3119.6580.685.49-19.56
Interest Expense
-0.02-0.03-0.04-0--
Interest & Investment Income
6.286.554.484.40.60.52
Currency Exchange Gain (Loss)
-0.47-0.470.030.011.06-0.39
Other Non Operating Income (Expenses)
1.30.070.630.310.080
EBT Excluding Unusual Items
54.26158.43124.7485.47.23-19.43
Gain (Loss) on Sale of Assets
-0.03-0.03-0.01-0.01-0-0.02
Legal Settlements
---5.12--
Other Unusual Items
-----1.22
Pretax Income
54.23158.39124.7390.57.23-18.22
Income Tax Expense
-1.1419.222.6718.1-0.151.66
Net Income
55.36139.2102.0672.47.38-19.88
Net Income to Common
55.36139.2102.0672.47.38-19.88
Net Income Growth
-61.31%36.38%40.97%880.90%--
Shares Outstanding (Basic)
696969696969
Shares Outstanding (Diluted)
696969696969
Shares Change
-0.46%0.08%0.06%0.08%--
EPS (Basic)
0.812.021.481.050.11-0.29
EPS (Diluted)
0.812.021.481.050.11-0.29
EPS Growth
-61.13%36.25%40.82%901.00%--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-7.5466.98128.76107.9697.01-10.96
Free Cash Flow Per Share
-0.110.971.871.571.41-0.16
Dividend Per Share
1.0801.0800.7040.461--
Dividend Growth
66.39%53.43%52.65%---
Gross Margin
76.45%85.15%82.46%79.69%60.91%39.17%
Operating Margin
27.72%49.27%48.04%44.47%8.49%-79.61%
Profit Margin
32.54%45.03%40.98%39.90%11.42%-80.92%
Free Cash Flow Margin
-4.43%21.67%51.70%59.50%150.15%-44.61%
EBITDA
56.98162.03129.2489.914.89-10.23
EBITDA Margin
33.50%52.41%51.90%49.55%23.04%-41.62%
D&A For EBITDA
9.829.739.599.229.49.33
EBIT
47.17152.3119.6580.685.49-19.56
EBIT Margin
27.72%49.27%48.04%44.47%8.49%-79.61%
Effective Tax Rate
-12.12%18.17%20.00%--